Aemetis (AMTX) PT Set at $2.00 by B. Riley

Aemetis (NASDAQ:AMTX) received a $2.00 target price from stock analysts at B. Riley in a report issued on Friday, March 16th. The firm currently has a “hold” rating on the specialty chemicals company’s stock. B. Riley’s target price suggests a potential upside of 37.93% from the company’s current price.

AMTX has been the topic of several other reports. Ascendiant Capital Markets began coverage on Aemetis in a report on Tuesday, March 6th. They set a “buy” rating and a $2.00 target price on the stock. Zacks Investment Research downgraded Aemetis from a “hold” rating to a “sell” rating in a research report on Tuesday, February 13th.

How to Become a New Pot Stock Millionaire

Shares of NASDAQ:AMTX traded down $0.16 during midday trading on Friday, hitting $1.45. 124,396 shares of the stock were exchanged, compared to its average volume of 2,729,400. Aemetis has a 52-week low of $0.45 and a 52-week high of $3.12. The company has a current ratio of 0.37, a quick ratio of 0.20 and a debt-to-equity ratio of -1.87. The firm has a market cap of $29.32, a price-to-earnings ratio of -1.63 and a beta of -0.67.

An institutional investor recently bought a new position in Aemetis stock. Atlantic Trust Group LLC bought a new position in shares of Aemetis Inc (NASDAQ:AMTX) during the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm bought 1,468,507 shares of the specialty chemicals company’s stock, valued at approximately $1,278,000. Atlantic Trust Group LLC owned approximately 7.41% of Aemetis as of its most recent SEC filing. 16.20% of the stock is owned by institutional investors.

WARNING: This news story was first posted by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are accessing this news story on another publication, it was illegally copied and reposted in violation of US and international trademark & copyright legislation. The correct version of this news story can be accessed at https://www.dispatchtribunal.com/2018/04/09/aemetis-amtx-given-a-2-00-price-target-at-b-riley.html.

Aemetis Company Profile

Aemetis, Inc operates as an international renewable fuels and bio-chemicals company in North America and India. It focuses on the production of advanced fuels and chemicals through the acquisition, development, and commercialization of technologies that replace traditional petroleum-based products by conversion of first-generation ethanol and biodiesel plants into advanced bio refineries.

Receive News & Ratings for Aemetis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aemetis and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply